These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

546 related articles for article (PubMed ID: 7536898)

  • 1. Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Côté F; Julien JP
    Nature; 1995 May; 375(6526):61-4. PubMed ID: 7536898
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Altered ionic conductances in axons of transgenic mouse expressing the human neurofilament heavy gene: A mouse model of amyotrophic lateral sclerosis.
    Kriz J; Meier J; Julien JP; Padjen AL
    Exp Neurol; 2000 Jun; 163(2):414-21. PubMed ID: 10833316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective axonal transport of neurofilament proteins in neurons overexpressing peripherin.
    Millecamps S; Robertson J; Lariviere R; Mallet J; Julien JP
    J Neurochem; 2006 Aug; 98(3):926-38. PubMed ID: 16787413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice.
    Meier J; Couillard-Després S; Jacomy H; Gravel C; Julien JP
    J Neuropathol Exp Neurol; 1999 Oct; 58(10):1099-110. PubMed ID: 10515233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superoxide dismutase and neurofilament transgenic models of amyotrophic lateral sclerosis.
    Morrison BM; Morrison JH; Gordon JW
    J Exp Zool; 1998 Sep-Oct 1; 282(1-2):32-47. PubMed ID: 9723164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal profiles of neuronal degeneration, glial proliferation, and cell death in hNFL(+/+) and NFL(-/-) mice.
    McLean JR; Sanelli TR; Leystra-Lantz C; He BP; Strong MJ
    Glia; 2005 Oct; 52(1):59-69. PubMed ID: 15920739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for neurofilaments in the pathogenesis of amyotrophic lateral sclerosis.
    Julien JP
    Biochem Cell Biol; 1995; 73(9-10):593-7. PubMed ID: 8714677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A simple test to monitor the motor dysfunction in a transgenic mouse model of amyotrophic lateral sclerosis.
    Collard JF; Julien JP
    J Psychiatry Neurosci; 1995 Jan; 20(1):80-2. PubMed ID: 7865504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mice overexpressing the human neurofilament heavy gene as a model of ALS.
    Julien JP; Côté F; Collard JF
    Neurobiol Aging; 1995; 16(3):487-90; discussion 490-2. PubMed ID: 7566355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequence variants in human neurofilament proteins: absence of linkage to familial amyotrophic lateral sclerosis.
    Vechio JD; Bruijn LI; Xu Z; Brown RH; Cleveland DW
    Ann Neurol; 1996 Oct; 40(4):603-10. PubMed ID: 8871580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extra axonal neurofilaments do not exacerbate disease caused by mutant Cu,Zn superoxide dismutase.
    Couillard-Després S; Meier J; Julien JP
    Neurobiol Dis; 2000 Aug; 7(4):462-70. PubMed ID: 10964615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
    Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
    Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1.
    Nguyen MD; Larivière RC; Julien JP
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):12306-11. PubMed ID: 11050249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degeneration of axons in spinal white matter in G93A mSOD1 mouse characterized by NFL and α-internexin immunoreactivity.
    King AE; Blizzard CA; Southam KA; Vickers JC; Dickson TC
    Brain Res; 2012 Jul; 1465():90-100. PubMed ID: 22609817
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disruption of dynein/dynactin inhibits axonal transport in motor neurons causing late-onset progressive degeneration.
    LaMonte BH; Wallace KE; Holloway BA; Shelly SS; Ascaño J; Tokito M; Van Winkle T; Howland DS; Holzbaur EL
    Neuron; 2002 May; 34(5):715-27. PubMed ID: 12062019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The complement factor C5a receptor is upregulated in NFL-/- mouse motor neurons.
    Humayun S; Gohar M; Volkening K; Moisse K; Leystra-Lantz C; Mepham J; McLean J; Strong MJ
    J Neuroimmunol; 2009 May; 210(1-2):52-62. PubMed ID: 19286267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins.
    Sahenk Z; Mendell JR
    J Neurosci Res; 1992 Aug; 32(4):481-93. PubMed ID: 1382136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytoskeletal defects in amyotrophic lateral sclerosis (motor neuron disease).
    Julien JP; Millecamps S; Kriz J
    Novartis Found Symp; 2005; 264():183-92; discussion 192-6, 227-30. PubMed ID: 15773754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deleting the phosphorylated tail domain of the neurofilament heavy subunit does not alter neurofilament transport rate in vivo.
    Yuan A; Nixon RA; Rao MV
    Neurosci Lett; 2006 Jan; 393(2-3):264-8. PubMed ID: 16266786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
    Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
    Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.